Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

45
MANAGING HYPERCALCEMIA Speaker: Dr. Dibbendhu Khanra Chairperson: Dr. A.K. Banerjee

Transcript of Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Page 1: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

MANAGING HYPERCALCEMIA

Speaker: Dr. Dibbendhu Khanra

Chairperson: Dr. A.K. Banerjee

Page 2: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

- most over-the-counter sold drug

- 43% Indian women on

supplement

- prescribed by doctors commonly

most abundant mineral of body

maintenance of strong bones

neuro-mascular action

blood clotting, blood pressure

hormone regulation

Calcium an unparallel hero

Page 3: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

3

Calcium- a sinister in disguise

Hypercalcaemia- Today’s concern!

..Some cases..

Page 4: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 1

Mr. K is a 41 year old patient– Mild depression– Behavioral abnormality– Headache– Fatigue– Difficulty concentrating– TSH - 2.06 (0.5 – 4.00)– calcium 12.4 mg/dl

(8.4 – 10.4 mg/dl)

Page 5: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 2

Mrs. C is a 57 year old patient, well

t-score – 1.3 (spine), 2. 8 (femur)

Calcium – 12. 5 (8.4 – 10.4 mg/dl)

weight loss and generalised weakness

Cough and hemoptysis

Page 6: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 3

• A 58-year-woman presented to ER• progressive Multiple sclerosis• Osteoporosis• calcium, 600 mg, 3 times daily• 5000-IU cholecalciferol supplement OD• tremors• Altered sensorium• serum calcium 15.2 mg/dL

Page 7: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• 30-year-old female• Fever, cough• Polyuria, polydypsia, GI upset• constipation, confusion, headache• CECT chest – hilar lympahedenopathy• serum calcium, 13.8 mg/d

CASE 4

Page 8: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• 50-year-old male• Diabetic for 10 years• Poorly controlled with OHA• HTN, anasarca, anaemia• serum calcium 14.8 mg/d

CASE 5

We will come back to the cases..

Page 9: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Learning Objectives

Calcium metabolism Defining hypercalcaemia Causes of hypercalcaemia Cl/f of hypercalceimia Diagnosis to hypercalcaemia Management

Page 10: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

10

Calcium Metabolism

Page 11: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

11

Defining Hypercalcemia

Page 12: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Defining Hypercalcemia

Page 13: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

13

Page 14: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Ca+

+

PTH

Vitamin D

MalignancyMedicines

Endocrine

Genetic

Causes

Page 15: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Clinical features

15

Renal ‘stone

Abdominal

‘moan’

Skeletal

‘bone’

Psychis

‘groan’

Also…

Page 16: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Clinical features (Cont.)

Digitalis toxicity

Page 17: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

A = high calcium levels means primary hyperparathyroidism unless the PTH is near zero

B = normocalcemic" hyperparathyroidism.this is the only group that we believe should

have a urinary calcium level performed

Page 18: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

It is IMPOSSIBLE to tell the difference between FHH and primary hyperparathyroidism

based upon the results of a 24-hour urine test

1. Urinary calcium can be anything (very low to very high) in Pr HyperPTHism.

2. The arbitrary cut off of urinary ca excretion/ 24 hr 100 lacks any rationality.

3. Nor elevated serum ca neither elevated urinary ca has any association with renal stones.

4. Low urinary ca does not always mean FHH.

FHH is so rare, that few doctors will ever see it. FHH is diagnosed incorrectly about 95-99% of the time

Page 19: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

19

Diagnostic Approach

Sestamibi N-scan

Familial Hypocalciuric Hypercalcemi

a

calcium is high and PTH is high, d/g is primary hyperparathyroidism.

IF calcium is mildly raised in background of highly elevated PTH, then urinary ca can be ordered to rule out FHH

Corrected serum calcium=Ionized calcium + 0.8(4-serum albumin)

Page 20: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 1

Neuropsychiatric complaints

Calcium 12.4 mg/dl

iPTH – 509 (12-72 pg/ml)

Thallium subtraction study: Left lower lobe parathyroid adenoma

Page 21: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 2

Weight loss and generalised weakness

Calcium – 12. 5 (8.4 – 10.4 mg/dl)

iPTH 21 (10 – 65.0 pg/ml)

PTHrp - elevated

Lung biopsy with IHC:Well differentiated, low grade squamous cell lung carcinoma

Page 22: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• calcium, cholecalciferol supplement• serum calcium14.6 mg/dL (15.2 mg/dL)• iPTH - 4 pg/mL (N12-65 pg/mL• 25-OH D level 103 ng/mL (N>30 ng/ml)

22

CASE 3

Vit D overdose

Page 23: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• CECT chest – hilar lympahedenopathy• serum calcium, 13.8 mg/d• iPTH - 4 pg/mL (N12-65 pg/mL• 1, 25-OH D level elevated• Serum ACEase – highly raised

23

CASE 4

Hilar LN Bx – non caseating granulomasSarcoidosis

Page 24: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• T2DM• CKD• serum calcium 14.8 mg/d• iPTH – 209 (12-72 pg/ml)

CASE 5

Hypercalcemia Associated with Renal Failure

Page 25: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

25

Hypocalcaemia is the common denominator Reversible (adaptive) growth of parathyroid gland

• Resistance to the normal level of PTH• Increased level of FGF23• Reduction in 1,25(OH)2 vitamin D

Hypercalcemia Associated with Renal Failure

Secondary Hyperparathyroidism

Tertiary Hyperparathyroidism

• Long-standing, inadequately treated chronic renal failure• True clonal outgrowth (irreversible)

Page 26: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

TREATMENT

Observation

Pharmacological

NonPharmacological

Surgery

Dialysis

Page 27: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Hypercalcemia: to treat or not to

27

Critical - > 14 mg %

Moderate - 12 to 14 mg %

Mild – 10.4 to 11.9 mg %

Normal – 8.5 to 10.3 mg %

1 • Aggressive therapy

2

• Start therapy• When

symptomatic• When

PrHyperPTHism

3• No therapy• Except

PrHyperPTHism

Hypercalcaemia should always be treated

Page 28: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Avoid factors that can aggravate hypercalcemia

28

- thiazide and lithium- volume depletion- prolonged bed rest or inactivity- high calcium diet (>1000 mg/day)

Page 29: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

The Four Rx Modalities

I.V. Saline Hydration

Dexamethason

e

Bisphos- phonate

s

Calcitonin

29

A

B C

D

Page 30: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Dr. Harold Copp isolated calcitonin from salmon sperm

Page 31: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Bisphosphonate:

MOA

Osteonecrosis of Jaw (ONJ)

 mandible > maxilla  Matrix metalloproteinase 2

Page 32: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

In HF, CKD; lowers ca by 1-3 mg/dl

Routine use not recommended

Calcitonin and hydration provide a rapid reduction, while a bisphosphonate provides a sustained effect

Do not give bisphosphonates until patient is fully rehydratedcontraindicated in patients with cr cl <10 mL/min

Caution with NSAIDS, ACE inhibitors, aminoglycosides

Treating hypercalcaemia is multidrug approach

Page 33: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Monitoring

Mildly elevated calcium

No previous episodes of life threatening hypercalcemia

Normal renal function Normal bone status

Surgery• Serum calcium level

> 1 mg % above normal• Creatinine clearance

< 60 ml/minute• Bone density: T score <–

2.5

at Any of 3 sites• Age younger than 50

years33

Asymptomatic patient ofParathyroid adenoma

Serum caserum creatinine

Bone density

Significant symptoms – Rx surgery

Page 34: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Surgical TherapyMinimally Invasive Parathyroidectomy (MIP)

an outpatient procedure Pre-op localization with Sestamibi Tc scan cervical block anesthesia minimal surgical incision Intra-op PTH level obtained before and 5 mins after removal If PTH levels fall by greater than 50% operation terminated IF PTH Levels fall by less than 50%, full neck exploration clear-cut cost benefit Accepted in asymptomatic patients not proper for multiple tumour or large tumours

Page 35: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• If an enlarged gland is found, a normal gland should be sought.

• if an intra-operative frozen section biopsy of a normal-sized second gland confirms its histologic normality, no further exploration, biopsy, or excision is needed.

• recurrence rate of hyper-parathyroidism may be high if a second abnormal gland is missed.

• all four glands be sought

• most of the total parathyroid tissue mass be removed.

• unnecessary surgery & un-acceptable rate of hypoparathyroidism and hypocalcamia.

35

SURGICAL THERAPY (cont.)

Conventional

Page 36: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Surgery for MEN syndrome Conventional

• totally remove three glands with partial excision of the fourth gland

• care is taken to leave a good blood supply for the remaining gland

• total parathyroidectomy with immediate transplantation of a portion of a removed, minced parathyroid gland into the muscles of the forearm

• surgical excision is easier from the ectopic site in the arm if there is recurrent hyperfunction

36

Page 37: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 1

calcium 12.4 mg/dl

(8.4 – 10.4 mg/dl)

parathyroid adenoma

M/N= Surgery (MIP)

Page 38: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

CASE 2

Malignancy related hypercalcaemia

(Breast, Lung, Lymphoma, Thyroid, Kidney, Prostate, Multiple Myeloma)

N Saline calcitonin Zoledronic acid

Page 39: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

39

CASE 3

• Vit D overdose• Half life of Vit D is very short

no further treatment required• Withhold Vit D• Steroid can be used

Page 40: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• Acute symptomatic hypercalcaemia• Sarcoidosis (granulomatous disease; DHCC

related)• NS• Steroid

40

CASE 4

Page 41: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

• Hypercalcemia Associated with Renal Failure• Secondary hyperparathyroidism• calcitriol

CASE 5

Page 42: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Hypercalcemia Associated with Renal Failure

• Dialysis if life threatening

Secondary hyperparatyroidism• restriction of dietary phosphate, • the use of non-absorbable antacids• careful, selective addition of calcitriol

Tertiary Hyperparatyroidism• Partial removal of parathyroid gland

42

Page 43: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

43

In CKD

Dialysis Controversial

Malignancy or Vit D associated cases

Avoid factors that can

aggravate hypercalcemia

SUMMARY

Page 44: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

Take home messages

• Most common cause of hypercalcaemia is primary hyperparathyroidism

• Any hypercalcaemia should be worked up and treated. • First investigation to seek for is an intact PTH• Surgery is often provided to apparently aysmptomtic

patients of primary hyperparathyroidism• FHH, practically does NOT occur• Hydration is the mainstay of therapy• Managing hypercalcaemia is a multidrug approach• Calcitriol can be given in CKD associated hypercalaemia

Page 45: Managing hypercalcaemia presented on CMC, Kol, 1.10.2013

45

THANK YOU

[email protected]